SPY313.78-3.27 -1.03%
DIA259.04-3.96 -1.51%
IXIC10,343.89-89.76 -0.86%

HC Wainwright & Co. Maintains Neutral on Intercept Pharmaceuticals, Lowers Price Target to $48

HC Wainwright & Co. analyst Ed Arce maintains Intercept Pharmaceuticals (NASDAQ:ICPT) with a Neutral and lowers the price target from $92 to $48.

Benzinga · -
HC Wainwright & Co. analyst Ed Arce maintains Intercept Pharmaceuticals (NASDAQ: ICPT) with a Neutral and lowers the price target from $92 to $48.